School of Medicine
Showing 1-10 of 16 Results
-
Anthony Harris
Postdoctoral Scholar, Genetics
BioAnthony Harris is a postdoctoral fellow in the Department of Genetics at Stanford School of Medicine, where he investigates the organization and function of the genome during cellular development. His research focuses on uncovering fundamental principles of chromosome structure, cellular differentiation, and genome stability. By combining experimental molecular biology, computational modeling, and third generation sequencing technologies, Dr. Harris aims to elucidate the mechanisms that shape chromatin architecture and direct genome maintenance. His interdisciplinary approach integrates cutting-edge quantitative analysis with traditional molecular techniques to advance understanding of the relationship between cellular organization and disease.
Dr. Harris has developed computational tools for genomic data analysis and applies data-driven strategies to study chromatin structure and gene regulation. His work has been published in leading journals, including EMBO Journal, Genetics, and Developmental Cell, with projects spanning meiosis regulation, transcriptional control, and genome integrity. These experiences reflect his commitment to understanding how chromatin organization and gene expression guide cell fate and function.
Dr. Harris earned his Bachelor of Science in Biochemistry from the University of Minnesota and his Ph.D. in Molecular and Cellular Biology from the University of California, Berkeley. He brings expertise in data analysis, computational biology, scientific writing, and collaborative research. His broad training spans biochemistry, cell biology, microbiology, genetics, and computational genomics. -
Rogelio A. Hernández-López
Assistant Professor of Bioengineering and of Genetics
Current Research and Scholarly InterestsOur group works at the interface of mechanistic, synthetic, and systems biology to understand and program cellular recognition, communication, and organization. We are currently interested in engineering biomedical relevant cellular behaviors for cancer immunotherapy.
